BEAMSTART Logo

Journalistic: [Y Combinator-backed] Pelago, a telemedicine start-up specializing in addiction treatment, closes $58 million in Series C funding round.

TechCrunch LogoTechCrunch1 mo ago

 Journalistic: [Y Combinator-backed] Pelago, a telemedicine start-up specializing in addiction treatment, closes $58 million in Series C funding round. - TechCrunch

Quick Summary:

Combing this knowledge with advances in technology, and growing acceptance for telehealth solutions, the co-founders to create a solution platform, Pelago.

Instead, it partners with employers and healthcare benefit providers, who in turn provide it as a service, respectively to employees or health plan members when they are actively seeking treatment for themselves (or their families if they are covered in the plans).

Sherwani, Maroof Ahmed (COO), and Sarim Siddiqui (head of product) all met at medical school before going on to found Pelago.


More Pictures

 Journalistic: [Y Combinator-backed] Pelago, a telemedicine start-up specializing in addiction treatment, closes $58 million in Series C funding round. - TechCrunch (Picture 1)

or

Article Details

Author / Journalist: Kate Park

Category: Technology

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-03-28 @ 12:55:01 (1 months ago)

News Timezone: GMT -5:00

News Source URL: techcrunch.com

Language: English

Article Length: 756 words

Reading Time: 5 minutes read

Sentences: 33 lines

Sentence Length: 23 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © TechCrunch

News ID: 20543990

View Article Analysis

About TechCrunch

TechCrunch Logo

Main Topics: Technology

Official Website: techcrunch.com

Update Frequency: 7 posts per day

Year Established: 2005

Headquarters: United States

News Last Updated: 16 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT -5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #20

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story " Journalistic: [Y Combinator-backed] Pelago, a telemedicine start-up specializing in addiction treatment, closes $58 million in Series C funding round." has 756 words across 33 sentences, which will take approximately 4 - 7 minutes for the average person to read.

Which news outlet covered this story?

The story " Journalistic: [Y Combinator-backed] Pelago, a telemedicine start-up specializing in addiction treatment, closes $58 million in Series C funding round." was covered 1 months ago by TechCrunch, a news publisher based in United States.

How trustworthy is 'TechCrunch' news outlet?

TechCrunch is a fully independent (privately-owned) news outlet established in 2005 that covers mostly technology news.

The outlet is headquartered in United States and publishes an average of 7 news stories per day.

It's most recent story was published 16 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #20543990
  • URL: https://beamstart.com/news/yc-backed-pelago-a-virtual-17116321735637

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $100,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2024 BEAMSTART. All Rights Reserved.